GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targeting Broad Spectrum Solid and Hematologic Malignancies Accepted for Presentation at ESMO IO Congress 2021
Stock Information for GT Biopharma Inc.
Loading
Please wait while we load your information from QuoteMedia.